Texas Heart Institute Journal (Sep 2024)

Fulminant Myocarditis in Patients With Autoimmune Disease That Requires Extracorporeal Membrane Oxygenation Support

  • Filip Depta, MD, PhD,
  • Ingrid Olejárová, MD, PhD,
  • Dušan Rybár, MD, PhD,
  • Pavol Murín, MD, PhD,
  • Marián Švajdler, MD, PhD,
  • Tomáš Grendel, MD, PhD

DOI
https://doi.org/10.14503/THIJ-24-8431
Journal volume & issue
Vol. 51, no. 2
pp. 1 – 9

Abstract

Read online

Myocarditis is a potentially life-threatening inflammatory disease of the myocardium, often resulting from infectious and immune-mediated responses. Clinical presentation in severe cases often results in a devastating illness requiring extracorporeal membrane oxygenation support as a result of cardiogenic shock. Although endomyocardial biopsy is still considered the gold standard for diagnosis, it often reveals nonspecific lymphocytic infiltration. Because the precise cause is usually unknown, the initial treatment typically involves immunosuppression and frequent assessment of myocardial contractility. This report presents 3 rare cases of autoimmune diseases (polymyositis, immunoglobulin G4–related disease, and systemic lupus erythematosus) that require extracorporeal membrane oxygenation support as a result of fulminant myocarditis, including their follow-up periods.

Keywords